×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Aplastic Anemia and MDS International Foundation

The Aplastic Anemia and MDS International Foundation is the world's leading nonprofit health organization dedicated to patients afflicted with bone marrow failure disease.
Dr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children.
Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.
Dr. Antonio Risitano, a hematologist from the Univeristy of Naples, discusses the most current thinking on PNH and its treatment. Questions answered include:
Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.
Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on treatment of children with aplastic anemia. This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.
Dr. Lucy Godley, University of Chicago, and Dr. Luca Malcovati, University of Pavia, discuss the highlights of their session on Genetics and Genomics of Bone Marrow Failure at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Dr. David Margolis, Medical College of Wisconsin, and Dr. Danielle Townsley, MedImmune, discuss the highlights of their session on Treatment Options for Aplastic Anemia at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018. Topics include precision medicine, eltrombopag, and bone marrow transplantation.
Dr. Antonio Risitano, University of Naples and Dr. Regis Peffault DeLatour, Hospital de St. Louis, discuss recent research on treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Dr. Toyosi Odenike, University of Chicago and Dr. Eric Padron, H. Lee Moffitt Cancer Center, discuss the highlights of their session on Non-Transplant Treatments for Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable